United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News Medincell’s Phase 3 trial for long-acting injectable olanzapine in schizophrenia reaches completion Medincell has announced the successful completion of the pivotal Phase 3 SOLARIS clinical trial for its long-acting injectable… byPallavi MadhirajuFebruary 10, 2025